The Impella heart pumps are used in critical care settings to help a patient’s heart pump blood, and they can be monitored remotely through the app.
Abiomed told the FDA these devices are classified as Non-Device Clinical Decision Support Software and Non-Device Medical Device Data Systems, but the regulatory agency disagrees.
“Though some functions of the Impella Connect System may be Non-Device-MDDS [the product’s alarms] provide patient-specific medical information to detect a life-threatening condition and display time-critical alarms intended to notify a healthcare provider,” the FDA said in its Oct. 10 letter. Because of this, the Impella pumps require premarket approval.
Abiomed is working with the FDA, a spokesperson said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
